Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Authors

  • ATM Iqbal Hasan Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • SA Ahsan Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • AKM F Rahman Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • CM Ahmed Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • M Safiuddin Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Md Harisul Hoque Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Ahsan Habib Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Tanjima Parvin Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Abu Salim Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Naveen Sheikh Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Jahanara Arzu Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Manzoor Mahmood Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Khurshed Ahmed Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Sajal K Banerjee Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Md Abu Siddique Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Mohammad Saifullah Patwary Department of Cardiology, Marks Medical College Hospital, Mirpur, Dhaka
  • Mohammad Abul Ehsan Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Mahmud Monowar Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Shorifur Rashid Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/uhj.v8i2.16083

Keywords:

Role of Percutaneous, Septal Ablation, Obstructive, Hypertrophic, Cardiomyopathy

Abstract

HCM is a relatively common genetic mediated primary cardiac disease which may cause sudden death in the young including competative athlets.PTSMA is an alternative therapeutic option for surgical septal myomectomy who are high risk for surgery and presented with severe disabling symptoms due to marked LV outflow obstruction. PTSMA is performed by injection of 1 to 4 ml of 96% to 98% ethanol into the target artery in 0.5 to 1.0 ml aliquots at 1 ml/min. Selection of patients for PTSMA includes those with severe symptoms refractory to maximum medical management associated with LV outflow gradient > 50 mm Hg and basal septal thickness > 18 mm. Successful outcome following septal ablation by LV outflow gradient often reduced to < 20 mm of Hg and improved from symptomatic standpoint.

DOI: http://dx.doi.org/10.3329/uhj.v8i2.16083

University Heart Journal Vol. 8, No. 2, July 2012

Downloads

Download data is not yet available.
Abstract
618
PDF
409

Downloads

Published

2013-08-05

How to Cite

Hasan, A. I., Ahsan, S., Rahman, A. F., Ahmed, C., Safiuddin, M., Hoque, M. H., Habib, A., Parvin, T., Salim, A., Sheikh, N., Arzu, J., Mahmood, M., Ahmed, K., Banerjee, S. K., Siddique, M. A., Patwary, M. S., Ehsan, M. A., Monowar, M., & Rashid, S. (2013). Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. University Heart Journal, 8(2), 110–112. https://doi.org/10.3329/uhj.v8i2.16083

Issue

Section

Review Articles